PT822986E - Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos - Google Patents
Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticosInfo
- Publication number
- PT822986E PT822986E PT96912205T PT96912205T PT822986E PT 822986 E PT822986 E PT 822986E PT 96912205 T PT96912205 T PT 96912205T PT 96912205 T PT96912205 T PT 96912205T PT 822986 E PT822986 E PT 822986E
- Authority
- PT
- Portugal
- Prior art keywords
- interleukin
- binding
- pct
- preparation
- pharmaceutical compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000273A IT1276555B1 (it) | 1995-04-28 | 1995-04-28 | Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni |
Publications (1)
Publication Number | Publication Date |
---|---|
PT822986E true PT822986E (pt) | 2003-07-31 |
Family
ID=11403338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96912205T PT822986E (pt) | 1995-04-28 | 1996-04-26 | Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos |
Country Status (11)
Country | Link |
---|---|
US (1) | US5972902A (pt) |
EP (1) | EP0822986B1 (pt) |
JP (2) | JP3373856B2 (pt) |
AT (1) | ATE233320T1 (pt) |
CA (1) | CA2218372C (pt) |
DE (1) | DE69626387T2 (pt) |
DK (1) | DK0822986T3 (pt) |
ES (1) | ES2191096T3 (pt) |
IT (1) | IT1276555B1 (pt) |
PT (1) | PT822986E (pt) |
WO (1) | WO1996034104A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2237114A1 (en) * | 1995-11-07 | 1997-05-15 | Kaneka Corporation | Autoantigens |
DE19704979A1 (de) * | 1996-02-07 | 1997-08-14 | Max Delbrueck Centrum | Retroviraler Vektor für den Gentransfer eines IL6-Antagonisten in humane hämatopoetische Stammzellen |
EP2011514B1 (en) | 1997-03-21 | 2012-02-29 | Chugai Seiyaku Kabushiki Kaisha | A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
IT1291932B1 (it) * | 1997-06-20 | 1999-01-21 | Angeletti P Ist Richerche Bio | Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma |
MXPA02008697A (es) | 2000-03-06 | 2003-04-14 | Sigma Tau Ind Farmaceuti | Uso de antagonistas de interleucina-6 para el tratamiento de enfermedades caracterizadas por altos niveles de aromatasa. |
DK1562968T3 (da) * | 2001-11-14 | 2013-10-28 | Janssen Biotech Inc | Anti-il-6-antistoffer, sammensætninger, fremgangsmåder og anvendelser |
US20050100550A1 (en) * | 2003-11-10 | 2005-05-12 | Mohit Trikha | Anti-angiogenic uses of IL-6 antagonists |
ITRM20050103A1 (it) * | 2005-03-10 | 2006-09-11 | Rocco Savino | Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi. |
JO3058B1 (ar) * | 2005-04-29 | 2017-03-15 | Applied Molecular Evolution Inc | الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها |
US8188235B2 (en) | 2008-06-18 | 2012-05-29 | Pfizer Inc. | Antibodies to IL-6 and their uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09505721A (ja) * | 1992-10-20 | 1997-06-10 | シータス オンコロジー コーポレイション | インターロイキン6レセプターアンタゴニスト |
IT1261787B (it) * | 1993-06-23 | 1996-06-03 | Angeletti P Ist Richerche Bio | Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. |
-
1995
- 1995-04-28 IT IT95RM000273A patent/IT1276555B1/it active IP Right Grant
-
1996
- 1996-04-26 PT PT96912205T patent/PT822986E/pt unknown
- 1996-04-26 AT AT96912205T patent/ATE233320T1/de not_active IP Right Cessation
- 1996-04-26 ES ES96912205T patent/ES2191096T3/es not_active Expired - Lifetime
- 1996-04-26 WO PCT/IT1996/000084 patent/WO1996034104A1/en active IP Right Grant
- 1996-04-26 CA CA002218372A patent/CA2218372C/en not_active Expired - Fee Related
- 1996-04-26 DE DE69626387T patent/DE69626387T2/de not_active Expired - Fee Related
- 1996-04-26 US US08/945,529 patent/US5972902A/en not_active Expired - Fee Related
- 1996-04-26 JP JP53233396A patent/JP3373856B2/ja not_active Expired - Fee Related
- 1996-04-26 EP EP96912205A patent/EP0822986B1/en not_active Expired - Lifetime
- 1996-04-26 DK DK96912205T patent/DK0822986T3/da active
-
2002
- 2002-09-05 JP JP2002259481A patent/JP2003153691A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US5972902A (en) | 1999-10-26 |
WO1996034104A1 (en) | 1996-10-31 |
JPH10506538A (ja) | 1998-06-30 |
CA2218372C (en) | 2001-07-31 |
ES2191096T3 (es) | 2003-09-01 |
EP0822986B1 (en) | 2003-02-26 |
DE69626387D1 (de) | 2003-04-03 |
JP2003153691A (ja) | 2003-05-27 |
JP3373856B2 (ja) | 2003-02-04 |
CA2218372A1 (en) | 1996-10-31 |
ITRM950273A1 (it) | 1996-10-28 |
ATE233320T1 (de) | 2003-03-15 |
IT1276555B1 (it) | 1997-11-03 |
DE69626387T2 (de) | 2003-12-11 |
DK0822986T3 (da) | 2003-04-28 |
ITRM950273A0 (it) | 1995-04-28 |
EP0822986A1 (en) | 1998-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI963101A (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
NO20003550L (no) | Farmasøytiske sammensetninger og anvendelse herav | |
TR199900318T2 (xx) | IL-8 resept�r antagonistleri. | |
BG109311A (en) | PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNFAL, AND HIS APPLICATION | |
PT822986E (pt) | Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos | |
HUP0303952A2 (hu) | Terápiás ágens gyermekkori krónikus artrítiszhez hasonló betegségekre | |
BRPI0409910A (pt) | métodos para o tratamento de doenças relacionadas com interleucina-6 | |
ES2144386T1 (es) | Ligando para el activador receptor de nf-kappa b, cuyo ligando es miembro de la superfamilia tnf. | |
ATE360032T1 (de) | Cystein-reiche rezeptoren-train | |
BR0114410A (pt) | Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade | |
IT9019677A0 (it) | Composizione farmaceutica solida e procedimento per la sua preparazione | |
DK1141286T3 (da) | Kæde af cytokinreceptorer | |
NO307784B1 (no) | Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on- derivater, farmasøytiske blandinger inneholdende dem og mellomprodukter for fremstilling derav | |
DK0613499T3 (da) | Humame IT-4-mutantproteiner | |
IL129527A0 (en) | A pharmaceutical composition containing soluble lymphotoxin-beta receptors | |
WO2000002582A3 (en) | Treatment of celiac disease with interleukin-15 antagonists | |
EP0816496A3 (de) | Nierenkarzinom-spezifische-T-Zellen | |
IL133632A (en) | Use of a specific 5ht2 receptor antagonist for the preparation of pharmaceutical compositions useful in the treatment of the sleep apnea syndrome | |
ATE251902T1 (de) | Pharmazeutische zusammensetzung zur reduzierung der mcp-1 proteinsynthese | |
TR200100921T2 (tr) | Terkipler ve bunların mide-özofagus geri akım hastalığı için kullanımı | |
IT8819835A0 (it) | Composizione dietetica eprocedimento per la sua preparazione. | |
HUP9903619A2 (hu) | 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény | |
DK0983361T3 (da) | Bakterielle pheromoner og anvendelser deraf | |
ITMI912002A0 (it) | Composizione farmaceutica solida e procedimento per la sua preparazione | |
MX9803791A (es) | Intermediarios novedosos y su uso para preparar bisindolilmaleimidas n,n'-puenteadas. |